Company Filing History:
3 out of 3,446 
1 out of 1,217 
Years Active: 1999-2015
Title: Lee J Helman: Innovator in Cancer Treatment
Introduction
Lee J Helman is a prominent inventor based in Bethesda, MD (US), known for her significant contributions to the field of cancer treatment. With a total of 4 patents, she has made remarkable strides in developing immunogenic peptides and related methods aimed at treating and preventing cancer.
Latest Patents
Her latest patents focus on immunogenic peptides and methods of use for treating and preventing cancer. These patents disclose various immunogenic peptides, related fusion proteins, and nucleic acids encoding these peptides or fusion proteins. Additionally, they cover conjugates, expression vectors, host cells, and antibodies. The patents also detail pharmaceutical compositions and vaccines designed for the treatment or prevention of cancer, including specific methods for stimulating T cells to kill tumor cells and methods for stimulating CD4 and CD8 T cells.
Career Highlights
Lee J Helman has had a distinguished career, working with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and The United States of America as represented by the Department of Health. Her work has significantly impacted the development of innovative cancer therapies.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including Jay A Berzofsky and Leon T Van Den Broeke.
Conclusion
Lee J Helman continues to be a vital force in the field of cancer research and treatment, with her innovative patents paving the way for future advancements in immunotherapy.